— Know what they know.
Not Investment Advice
Also trades as: 0HI3.L (LSE) · $vol 0M

ARWR Short Interest

Arrowhead Pharmaceuticals, Inc.
1W: +0.2% 1M: -9.8% 3M: -31.5% YTD: -12.9% 1Y: +55.3% 3Y: +132.0% 5Y: -12.0%
$59.03
+0.05 (+0.08%)
 
Weekly Expected Move ±4.7%
$53 $55 $58 $61 $63
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $8.3B mcap · 122M float · 1.74% daily turnover · Short 56% of daily vol
Credit Risk of going bust: higher than 52% of companies Debt: 9.4% of company value Bonds: $79.9M held by 47 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.78 (down 99%), Arrowhead Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $864.1M against a stock market value of $8.34B.
Distance to default 4.96 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $452.0M (short-term plus half of long-term), stock volatility 60.3%; Altman Z'' 1.13. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Short Volume Summary

2026-10-26
49.8%
Short Ratio
of total volume
52.6%
20-Day Avg
57.4%
50-Day Avg
▼ Falling
5-Day Trend
0.2M
Short Volume
0.4M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 185,917 377,764 49.2%
NYSE 19,419 27,171 71.5%
BATS 45 7,266 0.6%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms